Hematopoietic Stem Cells Transplantation (HSCT) Market Trends - Growing Demand for Personalized Medicine to Reach at CAGR of 5.75% by 2021

As a MarketResearchReports.Biz report, it covers all details inside analysis and opinion in “Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2017-2021”.


Albany, NY -- (SBWIRE) -- 10/04/2017 -- The global hematopoietic stem cells transplantation (HSCT) market to grow at a CAGR of 5.75% during the period 2017-2021.

HSCT is the most widely used stem-cell therapy, where blood from umbilical cord is used. Research is being undertaken to discover various sources (such as cord blood cells, bone marrow, and peripheral blood cells) of hematopoietic stem cells to treat various disorders like hematological malignancies, blood related disorders (leukemia and lymphoma), neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.

Stem-cell therapy has become controversial after developments in isolating and culturing of embryonic stem cells. Somatic cell nuclear transfer is the technique used in embryonic stem cell research to create stem cells and induced pluripotent stem cells. This controversy is related to abortion policies and human cloning. However, the changing regulatory landscape in countries like the US and Japan may help to accelerate the clinical trials.

Covered in this report
The report covers the present scenario and the growth prospects of the global hematopoietic stem cells transplantation (HSCT) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of hematopoietic stem cells transplantation (HSCT).

Get the Sample Copy Of this Report :

The market is divided into the following segments based on geography:

Technavio's report, Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Other prominent vendors
Beike Biotechnology
bluebird bio
Cellular Biomedicine Group
Cellular Dynamics International (a subsidiary of Fujifilm)
Cesca Therapeutics
CHA Biotech
Gamida Cell
Global Stem Cells Group
Translational Biosciences (a subsidiary of Medistem Panama)

Market driver
Rising number of HSCT
For a full, detailed list, view our report

Send An Enquiry :

Market challenge
High cost of HSCT
For a full, detailed list, view our report

Market trend
Growing demand for personalized medicine
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

To order report Call Toll Free: 866-997-4948 or send an email on